Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Más filtros













Base de datos
Intervalo de año de publicación
1.
Psychiatr Serv ; 73(7): 787-800, 2022 07.
Artículo en Inglés | MEDLINE | ID: mdl-34875848

RESUMEN

OBJECTIVE: The authors conducted a systematic review of studies evaluating vocational interventions for young people with psychiatric conditions to determine the extent to which services were adapted for young people and whether services promoted gains in postsecondary education and employment. METHODS: Five databases (PubMed, PsycINFO, Web of Science, Academic Search Premier, and ERIC) were searched. Sources eligible for inclusion were controlled studies published between 2000 and mid-2020 that evaluated a vocational intervention and examined postsecondary educational or employment outcomes for youths or young adults (ages 14-35 years) with psychiatric conditions. RESULTS: Ten studies met the inclusion criteria. Several of the studies evaluated services that were adapted for young people, including through the incorporation of educational supports. The most consistent finding was that services based on the individual placement and support (IPS) model improved employment outcomes more effectively than did comparison approaches and treatment as usual. Fewer studies assessed educational outcomes, and they yielded mixed results; however, recent findings from a controlled trial indicate that an enhanced IPS intervention that included well-specified supported education and skills training led to significantly superior outcomes in both education and employment. CONCLUSIONS: These results provide support for the efficacy of IPS-based services to improve employment outcomes among young people with psychiatric conditions and suggest that adapting IPS to include comprehensive educational supports and skills training may be important for efforts to improve postsecondary educational outcomes. Additional well-controlled intervention studies that examine educational and longer-term outcomes should further inform the development and delivery of vocational services for this population.


Asunto(s)
Empleos Subvencionados , Trastornos Mentales , Adolescente , Adulto , Escolaridad , Humanos , Trastornos Mentales/terapia , Rehabilitación Vocacional/métodos , Adulto Joven
2.
Psychiatr Rehabil J ; 40(1): 103-107, 2017 03.
Artículo en Inglés | MEDLINE | ID: mdl-28368183

RESUMEN

OBJECTIVE: Given the poor educational outcomes associated with psychiatric conditions, we developed Focused Academic Strength Training (FAST), a 12-week strategy-focused cognitive remediation intervention designed to improve academic functioning among college students with psychiatric conditions. Here we report initial results from a randomized controlled trial of FAST. METHOD: Seventy-two college students with mood, anxiety, and/or psychotic disorders were randomized to receive FAST or services as usual and were assessed at baseline and 4 months (posttreatment). RESULTS: Repeated-measures analyses of variance indicated FAST-associated improvements in self-reported cognitive strategy use (p < .001), self-efficacy (p = .001), and academic difficulties (p = .025). There were no significant treatment-related improvements in neuropsychological performance. CONCLUSIONS AND IMPLICATIONS FOR PRACTICE: FAST may lead to an increase in self-efficacy and cognitive strategy use, as well as a reduction in academic difficulties among students with psychiatric conditions. Future analyses with follow-up data through 12 months will address the potential of FAST to improve academic functioning among this population. (PsycINFO Database Record


Asunto(s)
Rendimiento Académico , Trastornos de Ansiedad/rehabilitación , Remediación Cognitiva/métodos , Trastornos del Humor/rehabilitación , Trastornos Psicóticos/rehabilitación , Estudiantes , Adolescente , Adulto , Función Ejecutiva/fisiología , Femenino , Humanos , Masculino , Persona de Mediana Edad , Evaluación de Programas y Proyectos de Salud , Autoeficacia , Universidades , Adulto Joven
4.
Ann Pharmacother ; 40(11): 1939-45, 2006 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-17018688

RESUMEN

BACKGROUND: Multidrug-resistant Acinetobacter baumannii (MDR-Ab) has emerged as an increasingly problematic cause of hospital-acquired infections in the intensive care unit (ICU). MDR-Ab is resistant to most standard antimicrobials but often retains susceptibility to polymyxin B and doxycycline. OBJECTIVE: To evaluate the efficacy and toxicity of polymyxin B and doxycycline in the treatment of MDR-Ab infections. METHODS: A retrospective chart review was conducted between March 2002 and May 2005 in patients who received doxycycline or polymyxin B for treatment of MDR-Ab infections in ICUs within Grady Memorial Hospital, Atlanta, GA. RESULTS: Thirty-seven patients with MDR-Ab infections were treated with polymyxin B or doxycycline. Median age was 41 years and median ICU length of stay was 18 days prior to acquisition of MDR-Ab. Clinical cure was observed in 22 of 29 (76%) evaluable patients treated with polymyxin B and 2 of 4 (50%) patients treated with doxycycline. In patients with follow-up cultures, microbiological cure was observed in 17 of 21 (81%) patients treated with polymyxin B and 2 of 3 (67%) patients treated with doxycycline. Nephrotoxicity developed in 21% (7 of 33) of patients who received polymyxin B. Neurotoxicity was observed in 2 (6%) patients who received polymyxin B. No adverse reactions were observed with doxycycline. Overall, crude mortality was 27% (9 of 33) and 75% (3 of 4) among those who received polymyxin B and doxycycline, respectively. Three (9%) deaths were attributed to polymyxin B treatment failure, and no deaths were attributed to doxycycline treatment failure. CONCLUSIONS: Polymyxin B was effectively used to treat a substantial proportion of critically ill patients with MDR-Ab infection and was associated with a similar rate of nephrotoxicity as previously reported. Doxycycline monotherapy was used in a limited number of patients for the treatment of MDR-Ab; further evaluation of its efficacy in larger numbers of patients is warranted.


Asunto(s)
Infecciones por Acinetobacter/tratamiento farmacológico , Acinetobacter baumannii , Infección Hospitalaria/tratamiento farmacológico , Doxiciclina/administración & dosificación , Unidades de Cuidados Intensivos/estadística & datos numéricos , Polimixina B/administración & dosificación , Infecciones por Acinetobacter/epidemiología , Infecciones por Acinetobacter/mortalidad , Acinetobacter baumannii/efectos de los fármacos , Adolescente , Adulto , Anciano , Infección Hospitalaria/epidemiología , Infección Hospitalaria/mortalidad , Farmacorresistencia Bacteriana Múltiple , Quimioterapia Combinada , Femenino , Humanos , Masculino , Persona de Mediana Edad , Polimixina B/efectos adversos , Estudios Retrospectivos
6.
Behav Neurosci ; 118(6): 1240-52, 2004 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-15598133

RESUMEN

In operant tasks, control rats maintain high response rates under positive contingencies, when the probability of reinforcement is greater following a response (contingent reinforcement) than during the absence of that response. However, as contingencies approach zero, response rates decrease. In this experiment, under immediate contingent reinforcement, rats with medial septal lesions reduced their response rates, just like controls, when contingencies were shifted from positive toward zero. However, the septal rats were less sensitive to this contingency shift, compared with controls, when there was a 5-s delay between lever presses and contingent reinforcements. This lesion effect appeared to be due to a failure of voluntary response memory, which impaired sensitivity to operant contingencies when there was a delay between action and outcome.


Asunto(s)
Asociación , Condicionamiento Operante/fisiología , Aprendizaje Discriminativo/fisiología , Refuerzo en Psicología , Tabique del Cerebro/fisiología , Animales , Conducta Animal , Encefalopatías/fisiopatología , Electrólisis/métodos , Masculino , Ratas , Ratas Long-Evans , Tiempo de Reacción/fisiología , Esquema de Refuerzo , Tabique del Cerebro/anatomía & histología , Tabique del Cerebro/lesiones , Estadísticas no Paramétricas
7.
Ann Pharmacother ; 38(1): 142-5, 2004 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-14742808

RESUMEN

OBJECTIVE: To evaluate the safety and cardiovascular benefits of beta-blocker therapy in patients with chronic obstructive pulmonary disease (COPD). DATA SOURCES: Clinical literature was accessed through MEDLINE (1966-February 2003). Key search terms included chronic obstructive pulmonary disease and adrenergic beta-antagonists. DATA SYNTHESIS: beta-Blockers are often avoided in patients with COPD because of fear of bronchoconstriction, despite the known cardiovascular mortality benefits. A review of studies evaluating the use of beta-blockers in COPD was undertaken. CONCLUSIONS: The literature supports the safety and mortality benefits of using beta-blockers in COPD. Patients with mild to moderate COPD should receive cardioselective beta-blocker therapy when a strong indication exists.


Asunto(s)
Antagonistas Adrenérgicos beta/uso terapéutico , Enfermedad Pulmonar Obstructiva Crónica/tratamiento farmacológico , Revisión de la Utilización de Medicamentos , Humanos , Medición de Riesgo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA